Screening of HIV infection: role of molecular and immunological assays (Q34527302)

2 August 2017

1 reference

title

Screening of HIV infection: role of molecular and immunological assays (English)

1 reference

2 August 2017

1 reference

Bernard Weber

1

1 reference

2 August 2017

1 May 2006

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

2 August 2017

1 reference

2 August 2017

6

1 reference

2 August 2017

3

1 reference

2 August 2017

399-411

1 reference

Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra

2 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

21 January 2018

Primary HIV Infection.

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

First human immunodeficiency virus-1 group O infection in a European blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Sensitivity of HCV RNA and HIV RNA blood screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Clinical significance of nondiscriminated reactive results with the Chiron Procleix HIV-1 and HCV assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Direct HIV testing in blood donations: variation of the yield with detection threshold and pool size

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

First report of human immunodeficiency virus transmission via an RNA-screened blood donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Detection of acute infections during HIV testing in North Carolina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24gag

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Fourth generation human immunodeficiency virus (HIV) screening assays with an improved sensitivity for p24 antigen close the second diagnostic window in primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Reduction of the diagnostic window in three cases of human immunodeficiency-1 subtype E primary infection with fourth-generation HIV screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Comparative evaluation of the VIDAS HIV DUO Ultra assay for combined detection of HIV-1 antigen and antibodies to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

p24 Antigen detection assay modified with a booster step for diagnosis and monitoring of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

HIV RNA testing in the context of nonoccupational postexposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Redefining the HIV-infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

False negative anti-HIV-1/HIV-2 ELISAs in acute HIV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

[Application of molecular biology to blood transfusion safety: the nucleic acid testing]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Screening tests combined with p24 antigen and anti-HIV antibodies in early detection of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Evidence for a diagnostic window in fourth generation assays for HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.3.399

21 January 2018

Identifiers

DOI

10.1586/14737159.6.3.399

1 reference

2 August 2017

1 reference

PubMed ID

16706742